Aranda RJ, Guerrero-Naranjo JL, Larriva-Saad J, Karaegozian H, Jiménez SJM, Cervantes-Fanning P, Quiroz MH

Language: Spanish
References: 14
Page: 25-29
PDF size: 524.35 Kb.

ABSTRACT

Purpose. Creation of retinal detachment is an essential component of macular translocation. The purpose of the study is to avoid mechanical methods that damage the integrity of the retina and promote the appearance of PVR.
Methods. Hialuronidase (0.30 ml) and ACS-300 (0.50 ml) at different concentrations were injected into de vitreous cavity of 10 pigmented rabbits with a two week separation between each other. All rabbits were observed at 24, 36 and 72 h and also 1, 2, 3 and 4 weeks by ophtalmoscopy. ERG was performed before, during and after to evaluate de safety of ACS-300. Three eyes were enucleated and examined by electronic microscopy.
Results. In 87.5% of the eyes, partial or total retina detachment was observed in an average of time of 48 h, and in 100% of the eyes the retina reattached spontaneously in an average of time of 2-3 weeks. No adverse effects were detectable by ERG or electronic microscopy.
Conclusions. Intravitreal injection of hialuronidase and ACS-300 is a safe non-mechanical method for creating retinal detachment in rabbits and that may be effective for macular translocation.

REFERENCES

1. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophtalmology 1992; 99:933-943.

2. Atmaca LS, Ozmert E, Idil A. Natural progression of age– related macular degeneration. Ann Ophtalmol 1993; 25(11):412-7.

3. Bird A. Age–related macular disease. Br J Ophtalmol 1996; 80(1):2-3.

4. Klaver CC, Assink JJ y col. Smoking is also associated with age–related macular degeneration in persons aged 85 years and older: The Rotterdam Study. Arch Ophtalmol 1997; 115(7):945-52.

5. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in agerelated macular degeneration: results of a randomized clinical trial. Arch Ophtalmol 1991;109:1220-1231.

6. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: update findings from two clinical trials. Arch Ophtalmol 1993; 111:1200-1209.

7. Holekamp NM, Thomas MA, Dickinson JD y col. Surgical removal of subfoveal choroidal neovascularization in presumed ocular histplasmosis: stability of early visual results. Ophthalmology 1997;104:22-26.

8. Bottoni F, Airaghi P, Perego E y col. Surgical removal of idiopathic, myopic and age-related subfoveal neovasculatization. Graefes Arch Clin Exp Ophthalmol 1996; 234:42-50.

9. de Juan EJr., Lowenstein A, Bressler NM, Alexander J. Traslocation of the retina for management of subfoveal choroidal neovascularization II: a Preliminary report in humans. Am J Ophtalmol 1998; 125(5):635-46.

10. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: I. Experimental studies in the rabbit eye. Graefes Arch Clin Exp Ophtalmol 1993; 231:629-634.

11. Akduman L, Karavellas MP, Mac Donald JC y col. Macular traslocation with retinotomy and retinal rotation for exudative age–related macular degeneration. Retina 1999; 19(5):418-23.

12. Cassidy L, Barry P, Shaw C y col. Platelet derived growth factor levels in vitreous of patients with vitreoretinal disorders. Br J Ophtalmol 1998; 82(2):181-5.

13. Lashkari K, Rahimi N, Kazlauskas A. Induction of arachidonic and metabolite release by human fibroblast in proliferative vitreorretinopathy. Invest Ophtalmol Vis Sci 1999; 341(1): 111-7.

14. Seaber JH, Machemer R. Adaptation to monocular torsion after macular traslocation. Graefes Arch Clin Exp Ophtalmol 1997; 235:76-81.